The Autoimmune Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Autoimmune Treatment Market?
The autoimmune treatment market has experienced substantial expansion in the past few years. Its size will increase from $7.72 billion in 2024 to $8.66 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.1%. The historical trend in the autoimmune treatment market shows significant growth.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Autoimmune Treatment Industry?
The Autoimmune Treatment market is projected to reach $14.66 billion by the year 2029, expanding at a Compound Annual Growth Rate (CAGR) of 14.1%.
Download Your Free Sample of the 2025 Autoimmune Treatment Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Autoimmune Treatment Market?
The key drivers in the autoimmune treatment market are:
• Emergence of innovative therapies such as precision medicine approaches, small molecule, and gene therapies.
• Increase in biopharmaceutical investments and growth of the biosimilar market.
• Advancements in biologics, targeted, and immunomodulatory therapies.
• Integration of digital health tools and adoption of telemedicine and remote monitoring.
Global Market Segmentation: Identifying Major Autoimmune Treatment Industry Segments
The autoimmune treatment market covered in this report is segmented –
1) By Product: Consumables And Assay Kits, Instruments, Services
2) By Service Type: Consultation And Diagnosis, Therapy And monitoring, Drug development
3) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases
4) By Drug Class: Anti-Inflammatory, Anti-Hyperglycemic, NSAIDs, Interferons, Other Drug Class
Pre-order the 2025 Autoimmune Treatment Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Autoimmune Treatment Market?
The key trends in the autoimmune treatment market are:
• Advancements in biologics and targeted therapies are shaping the future of the autoimmune treatment market.
• The use of immunomodulatory therapies is becoming a significant trend.
• There is an increased focus on treatment for rare autoimmune diseases.
• Digital health tools, telemedicine, and remote monitoring are being integrated into autoimmune treatment practices.
Who Are the Top Competitors & Leading Players in the Autoimmune Treatment Market?
Major companies in the autoimmune treatment market are:
• Abbott Laboratories
• Amgen Inc.
• Johnson & Johnson Services Inc.
• Eli Lilly and Company
• Pfizer Inc.
• Hoffmann-La Roche AG
• AstraZeneca PLC
• Bristol-Myers Squibb Company
• Autoimmune Inc.
• Siemens Healthcare Private Limited
• Thermo Fisher Scientific Inc.
• Biogen Idec Inc.
• Bayer Schering Pharma AG
• GSK PLC
• Genentech Inc.
• AbbVie Inc.
• Celgene Corporation
• Gilead Sciences Inc.
• Merck & Co. Inc.
• Novartis International AG
• Sanofi SA
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
• UCB SA
• Alexion Pharmaceuticals Inc.
• Amarin Corporation PLC
• AnaptysBio Inc.
• Apellis Pharmaceuticals Inc.
• Arena Pharmaceuticals Inc.
• Aurinia Pharmaceuticals Inc.
• BioCryst Pharmaceuticals Inc.
• Biohaven Pharmaceutical Holding Company Ltd.
• BioMarin Pharmaceutical Inc.
• bluebird bio Inc.
• Cabaletta Bio Inc.
• Catabasis Pharmaceuticals Inc.
• ChemoCentryx Inc.
• Coherus BioSciences Inc.
• Corbus Pharmaceuticals Holdings Inc.
• CSL Limited
• Cumberland Pharmaceuticals Inc.
• CytoDyn Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the autoimmune treatment market in 2024
